358 related articles for article (PubMed ID: 23631730)
1. Synergistic stimulation of antigen presenting cells via TLR by combining CpG ODN and poly(γ-glutamic acid)-based nanoparticles as vaccine adjuvants.
Shima F; Uto T; Akagi T; Akashi M
Bioconjug Chem; 2013 Jun; 24(6):926-33. PubMed ID: 23631730
[TBL] [Abstract][Full Text] [Related]
2. Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles.
Shima F; Akagi T; Uto T; Akashi M
Biomaterials; 2013 Dec; 34(37):9709-16. PubMed ID: 24016848
[TBL] [Abstract][Full Text] [Related]
3. Effect of Hydrophobic Side Chains in the Induction of Immune Responses by Nanoparticle Adjuvants Consisting of Amphiphilic Poly(γ-glutamic acid).
Shima F; Akagi T; Akashi M
Bioconjug Chem; 2015 May; 26(5):890-8. PubMed ID: 25865284
[TBL] [Abstract][Full Text] [Related]
4. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
[TBL] [Abstract][Full Text] [Related]
5. Size effect of amphiphilic poly(γ-glutamic acid) nanoparticles on cellular uptake and maturation of dendritic cells in vivo.
Shima F; Uto T; Akagi T; Baba M; Akashi M
Acta Biomater; 2013 Nov; 9(11):8894-901. PubMed ID: 23770225
[TBL] [Abstract][Full Text] [Related]
6. Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles.
Hamasaki T; Uto T; Akagi T; Akashi M; Baba M
Clin Vaccine Immunol; 2010 May; 17(5):748-56. PubMed ID: 20219877
[TBL] [Abstract][Full Text] [Related]
7. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles built by self-assembly of amphiphilic gamma-PGA can deliver antigens to antigen-presenting cells with high efficiency: a new tumor-vaccine carrier for eliciting effector T cells.
Yoshikawa T; Okada N; Oda A; Matsuo K; Matsuo K; Kayamuro H; Ishii Y; Yoshinaga T; Akagi T; Akashi M; Nakagawa S
Vaccine; 2008 Mar; 26(10):1303-13. PubMed ID: 18255205
[TBL] [Abstract][Full Text] [Related]
9. Induction of endoplasmic reticulum-endosome fusion for antigen cross-presentation induced by poly (γ-glutamic acid) nanoparticles.
Mukai Y; Yoshinaga T; Yoshikawa M; Matsuo K; Yoshikawa T; Matsuo K; Niki K; Yoshioka Y; Okada N; Nakagawa S
J Immunol; 2011 Dec; 187(12):6249-55. PubMed ID: 22095716
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity.
Matsuo K; Koizumi H; Akashi M; Nakagawa S; Fujita T; Yamamoto A; Okada N
J Control Release; 2011 Jun; 152(2):310-6. PubMed ID: 21402114
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of biodegradable nanoparticles with aluminum adjuvants: antigen uptake by dendritic cells and induction of immune response in mice.
Uto T; Akagi T; Toyama M; Nishi Y; Shima F; Akashi M; Baba M
Immunol Lett; 2011 Oct; 140(1-2):36-43. PubMed ID: 21693134
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of vaccines comprised of hydrophobically-modified poly(γ-glutamic acid) nanoparticles and antigen proteins using fluorescence imaging.
Toita R; Nakao K; Mahara A; Yamaoka T; Akashi M
Bioorg Med Chem; 2013 Nov; 21(21):6608-15. PubMed ID: 24045007
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution of (125)I-labeled polymeric vaccine carriers after subcutaneous injection.
Toita R; Kanai Y; Watabe H; Nakao K; Yamamoto S; Hatazawa J; Akashi M
Bioorg Med Chem; 2013 Sep; 21(17):5310-5. PubMed ID: 23830700
[TBL] [Abstract][Full Text] [Related]
14. Induction of potent adaptive immunity by the novel polyion complex nanoparticles.
Uto T; Akagi T; Akashi M; Baba M
Clin Vaccine Immunol; 2015 May; 22(5):578-85. PubMed ID: 25809631
[TBL] [Abstract][Full Text] [Related]
15. Self-assembling CpG DNA nanoparticles for efficient antigen delivery and immunostimulation.
Rattanakiat S; Nishikawa M; Takakura Y
Eur J Pharm Sci; 2012 Sep; 47(2):352-8. PubMed ID: 22771546
[TBL] [Abstract][Full Text] [Related]
16. Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles.
Uto T; Wang X; Akagi T; Zenkyu R; Akashi M; Baba M
Biochem Biophys Res Commun; 2009 Feb; 379(2):600-4. PubMed ID: 19121627
[TBL] [Abstract][Full Text] [Related]
17. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
Ebrahimian M; Hashemi M; Maleki M; Abnous K; Hashemitabar G; Ramezani M; Haghparast A
Int J Pharm; 2016 Dec; 515(1-2):708-720. PubMed ID: 27989827
[TBL] [Abstract][Full Text] [Related]
18. Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
Okamoto S; Yoshii H; Akagi T; Akashi M; Ishikawa T; Okuno Y; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2007 Nov; 25(49):8270-8. PubMed ID: 17977633
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-9 expression induced by tape-stripping triggers on effective immune response with CpG-oligodeoxynucleotides.
Inoue J; Aramaki Y
Vaccine; 2007 Jan; 25(6):1007-13. PubMed ID: 17049678
[TBL] [Abstract][Full Text] [Related]
20. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
